Get exclusive access to clinical data, case studies, videos, and more on breast biopsy.

Discover a selected list of scientific studies, watch expert cases and access exclusive workshop.

Could your current biopsy option
be missing a lurking threat?

Accurate and timely diagnosis is key for women and their futures1,2 Get exclusive access to clinical data
Breast cancer represents a significant burden for women :3-5

The leading cancer diagnosis
in women3

The leading cause of
cancer-related death in women4

The 4th most common cause of cancer-related mortality globally5

A deeper look reveals the truth
about breast cancer

Projections also indicate that breast cancer incidence and mortality
is going to rise significantly

/>

38%

By 2050, cases are expected to increase by 38% globally6

68%

By 2050, deaths are expected to increase by 68% globally6

Early and accurate diagnosis paired with effective management is the best chance patients with breast cancer have of successful treatment1,2,7

Choosing the right biopsy approach for breast health patients isn't always easy. While the benefits of core needle biopsy (CNB) and surgical excision are well established8,9, they can also be associated with the threat of false negative results or avoidable surgical risks.

It's why this website is dedicated to providing practical educational information on vacuum-assisted biopsy (VAB), vacuum-assisted excision (VAE), and breast tissue markers. By considering these methods alongside traditional approaches, such as CNB or surgical excision, you can assess which biopsy method is best suited to your breast health patients' individual needs

Improve Diagnostic Accuracy
in Breast Cancer Biopsy

Discover minimally invasive solutions that reduce false negatives
and improve patient outcomes

Vacuum-assisted biopsy (VAB)

Maximise your chances of achieving reliable results for patients first time.

  • Reduces the risk of false negatives10,11
  • Reduces the need for re-biopsy11,12
  • Results in less or equivalent pain for your patients during and after procedures10,13

Prioritise your patient's breast treatment journey today.

Learn more about VAB

VAB for a patient with a hypoechoic, 10 mm breast nodule.

Breast tissue markers

Improved precision across long-term care

  • Helps assess tumour size21
  • Differentiates between multiple lesions21
  • Improves precision during surgery21
  • Enhances long-term care, monitoring and follow-up22-24

Have confidence in your breast diagnostic accuracy and precision today.

Learn more about breast tissue markers

Breast tissue marker placement in a patient receiving a biopsy for a heterogenous, 20 mm breast nodule.

Patient with a breast fibroadenoma confirmed by core biopsy three years prior, receiving VAE due to increase in size from 11 mm to 23 mm.

Vacuum-assisted excision (VAE)

A minimally-invasive alternative to surgery

  • No compromise on efficacy14-16
  • A high complete resection rate, from 70 - 100%15,17-19
  • Appropriate for a range of lesions, including B3 lesions and high-risk lesions, and benign lesions such as fibroadenomas14-18,20

Protect your patients from the sting of avoidable surgical risks today.

Learn more about VAE

Explore our resources to learn more

  •

    BD EleVation ™

  •

    EnCor Enspire™